We suggest that the association which we see between methylation loss and increased TREX2 expression could be responsible for beneficial downstream events like improved immune response and the survival benefit observed in a subgroup of laryngeal cancer patients. The gene discussed is TREX2; the disease is laryngeal carcinoma.